|Bid||0.00 x 1000|
|Ask||0.00 x 800|
|Day's range||110.06 - 114.99|
|52-week range||74.25 - 214.07|
|Beta (5Y monthly)||0.75|
|PE ratio (TTM)||N/A|
|Earnings date||22 Nov 2021 - 26 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||120.00|
Holding on to stocks for the long term is hard. When stocks go down, many investors want to bail out. In this Motley Fool Live video recorded on Oct. 6, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss two stocks that you'll probably never want to sell.
SOUTH SAN FRANCISCO, Calif., October 13, 2021--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced an agreement with the Broad Institute for the distribution of a customized next-generation sequencing (NGS) target enrichment exome panel designed for the identification and research of a wide range of cancer, rare and inherited disease genes from patient samples. Twist wi
SAN FRANCISCO, October 12, 2021--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Steffen Hellmold to the newly created position of senior vice president, business development, data storage.